Abstract: A protection circuit is provided. A control circuit receives an input voltage. In a case that the input voltage is lower than a negative threshold voltage, the control circuit outputs a first control voltage to a surge bleeder circuit through a first output end of the control circuit, to control the surge bleeder circuit to discharge the input voltage and output a first bleeder current. In a case that the input voltage is higher than a positive threshold voltage, the control circuit outputs a second control voltage to the surge bleeder circuit through a second output end of the control circuit, to control the surge bleeder circuit to discharge the input voltage and output a second bleeder current.

Abstract: Wolfberry glycopeptide composition and methods for preparing and using the same, the part with a molecular weight distribution of 1000 Da to 10000 Da of the wolfberry glycopeptide accounts for 50-85% on the HPLC differential refractive index map; and the protein content is 20-35% weight percentage, neutral polysaccharide content is 20-35% weight percentage. Optionally, the uronic acid content is 5-20% weight percentage. The preparation method of the present invention removes part of insoluble impurities by a heating flocculation method, instead of the conventional organic solvent extraction process, and without using any organic solvents in the whole process.

Abstract: The present disclosure provides an interaction method and an interaction device for a search result. The method includes: in response to determining that an interaction operation is performed, by a user of an electronic device, on the search result through a browser, extracting an interaction instruction based on the interaction operation; generating a guiding interaction step matching with the interaction instruction based on a preset rule; and prompting the user based on the guiding interaction step, such that the user performs interaction with the search result based on the guiding interaction step.

Abstract: The present invention provides a semiconductor container which is made of composite material. The composite material is selected from a group consisting of a graphene material doped cycloolefin copolymer (COC), a graphene material doped cycloolefin polymer (COP) and a graphene material doped cyclic block copolymer (CBC). The content of the graphene material ranges from 0.6% to 8.0% by weight in each composite material.

Abstract: The present invention discloses an antibody specifically binding to a human endothelin receptor and uses thereof, where the antibody can inhibit the functions of the human endothelin receptor. The present invention includes the preparation, cloning, expression, and characterization of the antibody. The present invention can be used to effectively treat pulmonary arterial hypertension, a disease associated with pulmonary arterial hypertension, and a reproductive organ cancer in a human.

Abstract: A computer-implemented method for selecting one or more providers having one or more specialties for a network available to members while satisfying one or more constraints, the method comprising: at a first computing device: receiving, from a second computing device separate and distinct from the first computer, a network provider request to select an optimized network of providers, the request including: a desired objective including at least one of provider cost minimization, provider average quality maximization and provider total volume maximization, one or more geographical designations, computing an optimized provider network of one or more selected providers including: applying a model that produces a non-optimized provider network of one or more providers having one or more specialties that satisfies the desired objective for the one or more geographical designations of the members without consideration of the availability in the geographical designation of one or more providers having one or more sp

Abstract: Provided herein are a glucagon receptor (GCGR) antibody and its fusion protein with glucagon-like peptide-1 (GLP-1), and a pharmaceutical composition thereof. Also provided herein is a method for using the GCGR antibody and its fusion protein with GLP-1 to treat, prevent or improve one or more symptoms of hyperglycemia, type 2 diabetes, metabolic syndrome or dyslipidemia.

Abstract: An objective of the present application is to provide a road characterization method, comprising: acquiring a target road, wherein the target road comprises one or more road segments; determining one or more atomic lanes corresponding to the road segments according to the road segment attribute information of the road segments; and determining lane association information related to the atomic lanes corresponding to the target road; wherein the one or more atomic lanes and the lane association information are used for characterizing the target road. The method can functionally completely describe objective connections of lanes within a target area, including lane connectivity and lane change feasibility.

Abstract: The present invention provides a method for processing a filter to obtain a calibration dust filter, and a method for off-site calibration using the calibration dust filter. In the present invention, a batch of filters that meets specific requirements is screened out as the basal filters, and then the basal filters are processed in an actual environment to obtain the calibration dust filters. The counted number of beta particles is measured before and after sampling, and then a correction factor K is inversely inferred. The beta attenuation suspended particulate analyzer is corrected using the correction factor K.

Abstract: An electrocardiogram information processing method and workstation system. The method includes receiving electrocardiogram data output by multiple devices; performs data analysis on the electrocardiogram data, and generating report data and stores same; receiving a report data query by a user, queries corresponding report data according to a user ID of the user, and generating report result list for display and output; receiving a selection by the user, and obtaining selected report data according to the selection; receiving a report data consultation request input by the user; obtaining a user ID of an associated user corresponding to the user ID according to the report data consultation request, and sending the report data to a user equivalent of the associated user according to the user ID of the associated user; and receiving a consultation result feedback data sent by the user equivalent of the associated user.

Abstract: The present disclosure relates to asymmetric ansa-metallocene catalyst compounds that include at least one indenyl ligand substituted at the 3-position with a C3-C40 ?-branched alkyl, such as 1-methylethyl, 1-methylpropyl, 1-methylbutyl, 1-ethylbutyl, 1,3-dimethylbutyl, 1-methyl-1-ethylbutyl, 1,1-diethylbutyl, 1-propylpentyl, and the like. Catalyst systems prepared with the catalyst compounds, polymerization methods using such catalyst systems, and polyolefins made using the polymerization methods are also described.

Abstract: A railway vehicle, a coupler, and a coupler body thereof. The coupler body comprises an upper traction platform, a lower traction platform, a lock chamber, and a pin hole. A traction surface of an upper traction platform and/or a lower traction platform is divided into a contact area and a yielding area along the direction approaching the lock chamber, an extension face of the end of the contact area close to the lock chamber is an M2 face, and the yielding area is positioned at the side of the M2 face close to the pin hole. The yielding area is positioned on the side of the contact area next to the lock chamber and there is a gap and no contact between the yielding area and a traction platform of a coupler knuckle.

Abstract: The present invention discloses an antibody specifically binding to a human endothelin receptor and uses thereof, where the antibody can inhibit the functions of the human endothelin receptor. The present invention includes the preparation, cloning, expression, and characterization of the antibody. The present invention can be used to effectively treat pulmonary arterial hypertension, a disease associated with pulmonary arterial hypertension, and a reproductive organ cancer in a human.

Abstract: A computer-implemented method for selecting one or more providers having one or more specialties for a network available to members while satisfying one or more constraints, the method comprising: at a first computing device: receiving, from a second computing device separate and distinct from the first computer, a network provider request to select an optimized network of providers, the request including: a desired objective including at least one of provider cost minimization, provider average quality maximization and provider total volume maximization, one or more geographical designations, computing an optimized provider network of one or more selected providers including: applying a model that produces a non-optimized provider network of one or more providers having one or more specialties that satisfies the desired objective for the one or more geographical designations of the members without consideration of the availability in the geographical designation of one or more providers having one or more sp